title: Deal watch: Valuation benefits of structure-enabled drug discovery.
authors.forename: Nigel
authors.initials: N
authors.lastname: Borshell
authors.forename: Tibor
authors.initials: T
authors.lastname: Papp
authors.forename: Miles
authors.initials: M
authors.lastname: Congreve
mesh_terms: D002986:Clinical Trials as Topic; D055808:Drug Discovery / Q000458:organization & administration*; D004345:Drug Industry / Q000458:organization & administration*; D004798:Enzymes / Q000737:chemistry / Q000378:metabolism; D006801:Humans; D013329:Structure-Activity Relationship
chemical_list: D004798:Enzymes